Literature DB >> 20926620

Toxicological evaluation of acyl glucuronides of nonsteroidal anti-inflammatory drugs using human embryonic kidney 293 cells stably expressing human UDP-glucuronosyltransferase and human hepatocytes.

Toshihisa Koga1, Ryoichi Fujiwara, Miki Nakajima, Tsuyoshi Yokoi.   

Abstract

The chemical reactivity of acyl glucuronide (AG) has been thought to be associated with the toxic properties of drugs containing carboxylic acid moieties, but there has been no direct evidence that AG formation was related to the toxicity. In the present study, the cytotoxicity and genotoxicity of AGs were investigated. Human embryonic kidney (HEK) 293 cells stably expressing UDP-glucuronosyltransferase (UGT) 1A3 (HEK/UGT1A3) were constructed to assess the cytotoxicity of AGs, and HEK/UGT1A4 cells were also used as a negative reference. After exposure to nonsteroidal anti-inflammatory drugs (NSAIDs) such as naproxen (1 mM), diclofenac (0.1 mM), ketoprofen (1 mM), or ibuprofen (1 mM) for 24 h, HEK/UGT1A3 cells produced AG in a time-dependent manner. However, HEK/UGT1A4 cells hardly produced AG. The cytotoxicity of HEK/UGT1A3 cells was not increased compared with that of HEK/UGT1A4 cells. In addition, the AG formed in NSAID-treated human hepatocytes was decreased from one-third to one-ninth by treatment with (-)-borneol, an inhibitor of acyl glucuronidation, but the cytotoxicity was increased. These results indicated that AG formation reflected the detoxification process in human hepatocytes. Furthermore, the possibility of genotoxicity from the AG formed in NSAID-treated HEK/UGT cells was investigated by the comet assay, and DNA damage was not detected in any HEK/UGT cell lines. In conclusion, the in vitro cytotoxic and genotoxic effects of the AGs of NSAIDs were investigated and AG was not found to be a causal factor in the toxicity.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20926620     DOI: 10.1124/dmd.110.035600

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  6 in total

1.  In silico prediction of acyl glucuronide reactivity.

Authors:  Tim Potter; Richard Lewis; Tim Luker; Roger Bonnert; Michael A Bernstein; Timothy N Birkinshaw; Stephen Thom; Mark Wenlock; Stuart Paine
Journal:  J Comput Aided Mol Des       Date:  2011-10-26       Impact factor: 3.686

2.  Acyl-glucuronide as a Possible Cause of Trovafloxacin-Induced Liver Toxicity: Induction of Chemokine (C-X-C Motif) Ligand 2 by Trovafloxacin Acyl-glucuronide.

Authors:  Ryo Mitsugi; Kyohei Sumida; Yoshiko Fujie; Robert H Tukey; Tomoo Itoh; Ryoichi Fujiwara
Journal:  Biol Pharm Bull       Date:  2016       Impact factor: 2.233

3.  Glucuronidation of drugs in humanized UDP-glucuronosyltransferase 1 mice: Similarity with glucuronidation in human liver microsomes.

Authors:  Yuki Kutsuno; Kyohei Sumida; Tomoo Itoh; Robert H Tukey; Ryoichi Fujiwara
Journal:  Pharmacol Res Perspect       Date:  2013-09-03

4.  Expression pattern of human ATP-binding cassette transporters in skin.

Authors:  Saya Takenaka; Tomoo Itoh; Ryoichi Fujiwara
Journal:  Pharmacol Res Perspect       Date:  2013-09-08

5.  Ibuprofen-Loaded Hyaluronic Acid Nanofibrous Membranes for Prevention of Postoperative Tendon Adhesion through Reduction of Inflammation.

Authors:  Chien-Tzung Chen; Chih-Hao Chen; Chialin Sheu; Jyh-Ping Chen
Journal:  Int J Mol Sci       Date:  2019-10-11       Impact factor: 5.923

6.  Expression of human solute carrier family transporters in skin: possible contributor to drug-induced skin disorders.

Authors:  Ryoichi Fujiwara; Saya Takenaka; Mitsuhiro Hashimoto; Tomoya Narawa; Tomoo Itoh
Journal:  Sci Rep       Date:  2014-06-11       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.